Comments on “Proton Pump Inhibitor–Associated Hypomagnesemia: What Do FDA Data Tell Us?”

Abstract

Get full access to this article

View all access options for this article.

References

Luk

Parsons

Lee

Hughes

. Proton pump inhibitor–associated hypomagnesemia: what do FDA data tell us? Ann Pharmacother. 2013;47:773-780.

Danziger

William

Scott

. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int. 2013;83:692-699.

Koulouridis

Alfayez

Tighiouart

. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case-control study. Am J Kidney Dis. 2013;62:730-737.